This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until it turns completely green. Thank you for your cooperation!
Category: 6. Health
-
Just a moment…
Just a moment… -
Just a moment…
Just a moment… This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until it turns completely green. Thank you for your cooperation!
Continue Reading
-
Just a moment…
Just a moment… This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until it turns completely green. Thank you for your cooperation!
Continue Reading
-
Assessing High-Dose Versus Standard-Dose Influenza Vaccine Protection Against Severe Disease Outcomes
This infographic summarizes findings from FLUNITY-HD, the largest ever individually randomized influenza vaccine effectiveness trial. Conducted across nearly half a million older adults, the study provides valuable real-world insights into the…
Continue Reading
-
Just a moment…
Just a moment… This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until it turns completely green. Thank you for your cooperation!
Continue Reading
-
Psychiatric Comorbidities, Quality-of-Life Burdens Associated with Pediatric Vitiligo
Pediatric vitiligo is linked with increased symptom burden, psychiatric comorbidity prevalence, and mild-to-moderate quality of life (QoL) impairment, new findings suggest, indicating the necessity of psychosocial evaluation integration.1These…
Continue Reading
-
Congo’s last Ebola patient has been discharged, raising hopes that outbreak might be over – The Washington Post
- Congo’s last Ebola patient has been discharged, raising hopes that outbreak might be over The Washington Post
- Last Ebola patient discharged in DR Congo, WHO says Al Jazeera
- WHO says DRC could declare end of Ebola outbreak by December Xinhua
Continue Reading
-
Sex-related disparities in migraine recognition and management: insights from a tertiary headache center cohort | The Journal of Headache and Pain
Patient selection & characteristics
Between December 2015 and January 2023, a total of 3,264 patients attended their first consultation at our tertiary headache center and were given out comprehensive history questionnaires. Of 1,780 returned, 364…
Continue Reading
-
EV-202: EV/Pembro Combo Shows 39% ORR in First-Line PD-L1+ HNSCC | Targeted Oncology
Enfortumab vedotin-ejfv (Padcev) in combination with pembrolizumab (Keytruda) yielded meaningful clinical activity as first-line treatment for patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) with a PD-L1…
Continue Reading
-
Largest-ever £26 million trial launches across UK to slow Parkinson’s disease
Image: ©Naeblys | iStock The world’s largest clinical trial for Parkinson’s disease has commenced, aiming to identify treatments that can slow or halt disease progression
The world’s largest clinical trial…
Continue Reading